JP2017014264A5 - - Google Patents

Download PDF

Info

Publication number
JP2017014264A5
JP2017014264A5 JP2016162327A JP2016162327A JP2017014264A5 JP 2017014264 A5 JP2017014264 A5 JP 2017014264A5 JP 2016162327 A JP2016162327 A JP 2016162327A JP 2016162327 A JP2016162327 A JP 2016162327A JP 2017014264 A5 JP2017014264 A5 JP 2017014264A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016162327A
Other versions
JP6177975B2 (ja
JP2017014264A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017014264A publication Critical patent/JP2017014264A/ja
Publication of JP2017014264A5 publication Critical patent/JP2017014264A5/ja
Application granted granted Critical
Publication of JP6177975B2 publication Critical patent/JP6177975B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016162327A 2011-11-03 2016-08-23 ポリエチレングリコールベースのアドレノメデュリンのプロドラッグおよびその使用 Active JP6177975B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11187735.3 2011-11-03
EP11187735 2011-11-03

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014539315A Division JP5995984B2 (ja) 2011-11-03 2012-10-30 ポリエチレングリコールベースのアドレノメデュリンのプロドラッグおよびその使用

Publications (3)

Publication Number Publication Date
JP2017014264A JP2017014264A (ja) 2017-01-19
JP2017014264A5 true JP2017014264A5 (ja) 2017-04-06
JP6177975B2 JP6177975B2 (ja) 2017-08-09

Family

ID=47146369

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014539315A Active JP5995984B2 (ja) 2011-11-03 2012-10-30 ポリエチレングリコールベースのアドレノメデュリンのプロドラッグおよびその使用
JP2016162327A Active JP6177975B2 (ja) 2011-11-03 2016-08-23 ポリエチレングリコールベースのアドレノメデュリンのプロドラッグおよびその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014539315A Active JP5995984B2 (ja) 2011-11-03 2012-10-30 ポリエチレングリコールベースのアドレノメデュリンのプロドラッグおよびその使用

Country Status (45)

Country Link
US (3) US9603936B2 (ja)
EP (2) EP2773376B1 (ja)
JP (2) JP5995984B2 (ja)
KR (2) KR102004668B1 (ja)
CN (2) CN107412740B (ja)
AR (2) AR088582A1 (ja)
AU (2) AU2012331244B2 (ja)
BR (1) BR112014010708B1 (ja)
CA (1) CA2854134C (ja)
CL (1) CL2014000948A1 (ja)
CO (1) CO7020863A2 (ja)
CR (1) CR20140184A (ja)
CU (1) CU24184B1 (ja)
CY (2) CY1117354T1 (ja)
DK (2) DK2773376T3 (ja)
DO (2) DOP2014000078A (ja)
EA (2) EA025631B1 (ja)
EC (2) ECSP14013326A (ja)
ES (2) ES2568063T3 (ja)
GT (1) GT201400085A (ja)
HK (1) HK1246147A1 (ja)
HR (2) HRP20160285T1 (ja)
HU (2) HUE036535T2 (ja)
IL (3) IL232037B (ja)
IN (1) IN2014CN03290A (ja)
JO (2) JOP20190001B1 (ja)
LT (1) LT3075395T (ja)
MA (1) MA35618B1 (ja)
ME (1) ME02379B (ja)
MX (2) MX350341B (ja)
MY (2) MY194197A (ja)
NO (1) NO3075395T3 (ja)
PE (2) PE20141219A1 (ja)
PL (2) PL3075395T3 (ja)
PT (1) PT3075395T (ja)
RS (2) RS56819B1 (ja)
SG (2) SG10201607516SA (ja)
SI (2) SI2773376T1 (ja)
TN (1) TN2014000185A1 (ja)
TR (1) TR201802124T4 (ja)
TW (2) TWI653051B (ja)
UA (1) UA111098C2 (ja)
UY (2) UY37922A (ja)
WO (1) WO2013064508A1 (ja)
ZA (1) ZA201600434B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2624626T3 (es) * 2011-11-03 2017-07-17 Bayer Intellectual Property Gmbh Ligadores basados en tirosina para la conexión desprendible de péptidos
EP2896400A1 (en) * 2014-01-17 2015-07-22 Université Catholique De Louvain Method for increasing the bioavailability of inhaled compounds
US11414474B2 (en) 2014-03-20 2022-08-16 University Of Miyazaki Long-acting adrenomedullin derivatives
EA201790699A1 (ru) 2014-09-26 2017-10-31 Байер Фарма Акциенгезельшафт Стабилизированные производные адреномедуллина и их применение
SG10202008963QA (en) * 2015-09-18 2020-10-29 Univ Miyazaki Long-acting adrenomedullin derivative
EP3604538A4 (en) * 2017-03-29 2020-12-30 University of Miyazaki LONG-ACTING ADRENOMEDULLINE DERIVATIVE
GB201707938D0 (en) * 2017-05-17 2017-06-28 Univ Sheffield Compounds
EP3986918A1 (en) 2019-06-18 2022-04-27 Bayer Aktiengesellschaft Adrenomedullin-analogues for long-term stabilization and their use
JP7498882B2 (ja) * 2019-12-05 2024-06-13 国立大学法人 宮崎大学 異常タンパク質蓄積性神経変性疾患の治療剤
WO2021198327A1 (en) 2020-04-03 2021-10-07 Bayer Aktiengesellschaft Liquid pharmaceutical formulations polyethylene glycol-based prodrugs of adrenomedullin and use
AU2021247501A1 (en) 2020-04-03 2022-10-27 Bayer Aktiengesellschaft Pharmaceutical formulations polyethylene glycol-based prodrugs of Adrenomedullin and use
KR20230093251A (ko) 2020-09-10 2023-06-27 프리시릭스 엔.브이. Fap에 대한 항체 단편
CN112457218B (zh) * 2020-11-05 2022-08-09 宁夏医科大学 2,4-二氨基丁酸衍生物的合成方法
AU2022330343A1 (en) 2021-08-20 2024-02-08 Bayer Aktiengesellschaft Process for the preparation of pegylated adrenomedullin, its intermediates and use thereof
WO2023203135A1 (en) 2022-04-22 2023-10-26 Precirix N.V. Improved radiolabelled antibody
WO2023213801A1 (en) 2022-05-02 2023-11-09 Precirix N.V. Pre-targeting

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5020040A (en) * 1987-06-24 1991-05-28 Digital Equipment Corporation Overwriting system for magneto-optical recording with self timing track
US4812590A (en) 1987-06-25 1989-03-14 Merck & Co., Inc. Carbamates of 4-hydroxyanisole as prodrugs for chemotherapy of melanoma
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US6624142B2 (en) 1997-12-30 2003-09-23 Enzon, Inc. Trimethyl lock based tetrapartate prodrugs
CA2292902C (en) 1999-12-24 2012-12-18 Alain Cadieux Use of calcitonin gene-related peptide in the prevention and alleviation of asthma and related bronchospastic pulmonary diseases
EP1243276A1 (en) 2001-03-23 2002-09-25 Franciscus Marinus Hendrikus De Groot Elongated and multiple spacers containing activatible prodrugs
US20050271615A1 (en) 2002-08-30 2005-12-08 Doron Shabat Self-immolative dendrimers releasing many active moieties upon a single activating event
AU2003282624A1 (en) 2002-11-14 2004-06-03 Syntarga B.V. Prodrugs built as multiple self-elimination-release spacers
PT1646813E (pt) 2003-07-23 2013-07-09 Ppg Ind Ohio Inc Vedante compósito e conjunto de janela
CA2786794C (en) 2004-03-23 2017-09-12 Complex Biosystems Gmbh Aromatic polymeric cascade prodrug linker reagent
WO2005116065A1 (en) 2004-05-24 2005-12-08 Institut De Cardiologie De Montréal Labelled adrenomedullin derivatives and their use for imaging and therapy
GB2427360A (en) 2005-06-22 2006-12-27 Complex Biosystems Gmbh Aliphatic prodrug linker
WO2008075968A1 (en) * 2006-12-20 2008-06-26 Ge Healthcare As Contrast agents
DK2155781T3 (da) 2007-05-11 2013-06-17 Inst Cardiologie Montreal Mærkede adrenomedullinderivater og deres anvendelse til visualisering og terapi
US9561285B2 (en) 2010-01-22 2017-02-07 Ascendis Pharma As Carrier-linked carbamate prodrug linkers
ES2624626T3 (es) * 2011-11-03 2017-07-17 Bayer Intellectual Property Gmbh Ligadores basados en tirosina para la conexión desprendible de péptidos

Similar Documents

Publication Publication Date Title
CH715083A2 (ja)
BR112019001667A2 (ja)
CN303578839S (ja)
CN303553158S (ja)
CN303539004S (ja)
CN303539286S (ja)
CN303540080S (ja)
CN303541556S (ja)
CN303541588S (ja)
CN303541634S (ja)
CN303542421S (ja)
CN303542624S (ja)
CN303543445S (ja)
CN303543670S (ja)
CN303543946S (ja)
CN303546544S (ja)
CN303548713S (ja)
CN303549147S (ja)
CN303549457S (ja)
CN303550147S (ja)
CN303550711S (ja)
CN303576593S (ja)
CN303551930S (ja)
CN303552019S (ja)
CN303553027S (ja)